TEMPLE THERAPEUTICS LLC;The Texas A&M University System;SCOTT & WHITE HEALTHCARE;Temple Therapeutics, LLC;TEXAS A & M UNIV SYS
发明人:
申请号：
EP11777695.5
公开号：
EP2566566B1
申请日:
2011.05.03
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, anti-apoptotic, immune modulatory and anti-tumorigenic properties. The invention includes administration of TSG-6, STC-1, or a combination thereof to the ocular as a treatment for an ocular disease, disorder or condition in a mammal.
